New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
06:59 EDTARIAARIAD's Ponatinib progressing well in Europe, says RBC Capital
RBC Capital's checks indicate ARIAD's Ponatinib EU CHMP recommendation could come as early as the 3rd week of March, putting EU approval at the end of Q2, ahead of guidance for Q3,and that France has used the drug under temporary authorization and has generated $1M + in differed revenues. Shares are Outperform rated.
News For ARIA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
12:11 EDTARIAOptions with increasing implied volatility
Subscribe for More Information
09:00 EDTARIAOn The Fly: Pre-market Movers
Subscribe for More Information
07:46 EDTARIAARIAD announces PRAC of EMA recommends Iclusig for continued EU use
Subscribe for More Information
October 6, 2014
07:36 EDTARIAARIAD, Bellicum announce revised license agreement for cell-signaling technology
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use